• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CUE HEALTH INC. CUE COVID-19 TEST FOR HOME AND OVER THE COUNTER (OTC) USE; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CUE HEALTH INC. CUE COVID-19 TEST FOR HOME AND OVER THE COUNTER (OTC) USE; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID Back to Search Results
Model Number C2020
Device Problem False Positive Result (1227)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 01/12/2022
Event Type  malfunction  
Event Description
Customer reports half of their 40 employees were receiving suspected false positive results when testing with the cue covid-19 test.Review of covid case tracker shows 26 employees who experienced positive results when testing with the cue covid-19 test, while testing negative with alternate covid-19 tests.See related cases for alternate false positive results.Individual 3: individual receiving a potential false positive result on (b)(6) 2022 when testing with the cue covid-19 test (lot 21006c, sn (b)(4).Individual obtained negative results when testing on (b)(6) 2022 with the binaxnow covid-19 and quickvue antigen tests, and on (b)(6) 2022 when testing with the binaxnow covid-19 antigen test.Individual experienced symptoms between (b)(6) 2022 to (b)(6) 20222.Individual experienced mild sore throat and weird taste on (b)(6) 2022.Individual attended in-person events, but did not specify any known exposures.
 
Manufacturer Narrative
Cartridges used by the consumer were not sent back for evaluation, therefore, the devices could not be evaluated.The customer provided information regarding the suspected false positive test and a member of the technical support group was able to perform data analysis.The complaint history was reviewed and there was one similar complaint against involved lot.The lot history record (lhr) was reviewed for the lot number in the complaint, and it passed release specifications.A technical support representative reviewed customer data and performed data analysis.All data values were normal and met acceptable criteria.Root cause was undetermined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CUE COVID-19 TEST FOR HOME AND OVER THE COUNTER (OTC) USE
Type of Device
REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
Manufacturer (Section D)
CUE HEALTH INC.
4980 carroll canyon rd.
suite 100
san diego CA 92121
Manufacturer Contact
roderick castillo
4980 carroll canyon rd.
suite 100
san diego, CA 92121
8332838378
MDR Report Key16026890
MDR Text Key308530142
Report Number3016758165-2022-00582
Device Sequence Number1
Product Code QJR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210180
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 12/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date09/07/2022
Device Model NumberC2020
Device Lot Number21006C
Was Device Available for Evaluation? No
Date Manufacturer Received01/27/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured12/07/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-